Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-04

Clinical Trial Update: Carnosine for Peripheral Arterial Disease [Phase 2]

View source ↗

Summary

Phase 2 trial of carnosine for peripheral arterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carnosine (carnosine)

Snippet

Sponsor: University of Louisville | Conditions: Peripheral Arterial Disease | Phase 2 | Status: COMPLETED